Global $1.09 Billion Biopharmaceutical Analytical Instrumentation Market, 2022 - Research and Markets
DUBLIN, April 06, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Biopharmaceutical Analytical Instrumentation Market, Forecast to 2022" report to their offering.
The global biopharmaceutical analytical instrumentation market generated a revenue of $1,092 million in 2015 and is expected to grow at a compound annual growth rate (CAGR) of 7.2% from 2015 to 2022.
The biosimilars segment, which is expected to reach $35 billion in 2025, will strongly drive the biopharmaceutical analytical instrumentation market. Strong analytical techniques will be used in the analysis of biosimilar drugs to improve product quality. Emerging economies' strong penetration into the global biosimilars segment will drive the need for analyzers. Key manufacturers are expanding their capabilities in these regions to bring advanced infrastructure to these markets. Complex biopharmaceutical processes demand advanced method solutions. A combination of sensitive instruments, smart software, and advanced methods will lead to the successful deployment of practices.
Key Questions this will Answer:
- What is the most important requirement from customers?
- How will the structure of the market change with time? Is the market ripe for acquisitions?
- Are the current solutions meeting customer needs, or is additional development needed?
Market Drivers
- The biosimilars segment, which is expected to reach $35 billion in 2025, will strongly drive the biopharmaceutical analytical instrumentation market
- Emerging economies strong penetration into the global biosimilars segment drives the need for analyzers
- Software fuels manufacturers' revenue from the biopharmaceutical market
Growth Opportunities
- Chromatographs and mass spectrometers are key to ensure a proper reproduction of the critical attributes of the innovator drug in the bio-similar.
- Manufacturers are expecting emerging countries to be the largest providers of biosimilars. Instrumentation manufacturers sell 100% of their instruments to biosimilar usage in some developing countries. This will help the emerging countries to be competitive and hold a strong position in the bio-similar market in the coming years.
Key Topics Covered:
1. Executive Summary
- Key Findings
- Market Engineering Measurements
- CEO's Perspective
2. Market Overview
- Market Definitions
- Key Questions This Study Will Answer
- Market Segmentation
3. Drivers and Restraints: Total Biopharmaceutical Analytical Instrumentation Market
- Market Drivers
- Drivers Explained
- Market Restraints
- Restraints Explained
4. Forecasts and Trends: Total Biopharmaceutical Analytical Instrumentation Market
- Market Engineering Measurements
- Forecast Assumptions
- Revenue Forecast
- Revenue Forecast Discussion
- Revenue Forecast by Region
- Percent Revenue Forecast by Region
5. Market Share and Competitive Analysis: Total Biopharmaceutical Analytical Instrumentation Market
- Market Share
- Market Share Analysis
- Competitive Environment
- Product Highlights
- Competitive Factors and Assessment
- Recommendations to Participants
6. Growth Opportunities and Companies to Action
- Growth Opportunity: Penetration of Biosimilars in Emerging Economies
7. Future of the Biopharmaceutical Analytical Instrumentation Market
- LIMS for Biopharmaceuticals
- Instrument Software - Overview
- Instrument Software - Future Predictions
- Mass Spectrometer Capability from 2012 to 2022To Serve the Biopharmaceutical Market
- Biosimilars versus Original Biologic Drugs - Overview
- Biosimilars - Implications to Mass Spectrometry
- Mass Spectrometry - Technology Roadmap
- Biopharmaceutical Processes - Current Challenges and Solutions
- Glycosylation - Challenges and Solutions
- Growth Opportunities in the Top 5 Segments - Mass Spectrometry
8. Mass Spectrometers Segment Analysis
- Key Findings
- Market Engineering Measurements
- Revenue Forecast
- Revenue Forecast Discussion
9. Chromatographs Segment Analysis
- Key Findings
- Market Engineering Measurements
- Revenue Forecast
- Revenue Forecast Discussion
10. Molecular Analysis Spectrometers Segment Analysis
- Key Findings
- Market Engineering Measurements
- Revenue Forecast
- Revenue Forecast Discussion
11. Elemental Analysis Spectrometers Segment Analysis
- Key Findings
- Market Engineering Measurements
- Revenue Forecast
- Revenue Forecast Discussion
12. North America Breakdown
- Key Findings
- Revenue Forecast
- Revenue Forecast Discussion
13. Europe Breakdown
- Key Findings
- Revenue Forecast
- Revenue Forecast Discussion
14. APAC and ROW Breakdown
- Key Findings
- Revenue Forecast
- Revenue Forecast Discussion
15. India Breakdown
- Key Findings India
- Indian Biosimilars Segment - Challenges and Solutions
- Indian Biosimilars Segment - Competitive Analysis
- Indian Biopharmaceutical Analytical Instrumentation Market - SWOT Analysis
Companies Mentioned
- Agilent
- Bruker Optics
- Cilson
- HORIBA Scientific
- JASCO
- Jeol
- Metrohm
- Ocean Optics
- PerkinElmer
- Renishaw
- SCIEX
- Shimadzu Scientific
- Spectro
- Thermo Fisher Scientific
- Waters
For more information about this report visit http://www.researchandmarkets.com/research/gmqrgz/global
Media Contact:
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article